Standard BioTools Inc. Assets, Fair Value Disclosure
Standard BioTools Inc. (LAB) had Assets, Fair Value Disclosure of $70.77 million as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:AssetsFairValueDisclosure · last filed 2016-08-09
- 2016-06-30: Assets, Fair Value Disclosure $70.77M.
- 2016-03-31: Assets, Fair Value Disclosure $77.74M.
- 2015-12-31: Assets, Fair Value Disclosure $83.58M.
- 2015-09-30: Assets, Fair Value Disclosure $96.12M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2016-06-30 | $70.77M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $77.74M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $83.58M 10-Q · filed 2016-08-09 |
| 2015-09-30 | $96.12M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $114.03M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $113.83M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $119.31M 10-K · filed 2016-02-29 |
| 2014-09-30 | $126.85M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $130.74M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $134.74M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $68.57M 10-K · filed 2015-02-26 |
| 2013-09-30 | $68.52M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $68.52M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $26.57M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $26.60M 10-K · filed 2014-03-12 |
| 2012-09-30 | $26.59M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $29.03M 10-Q · filed 2012-08-14 |
| 2011-12-31 | $43.21M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |